Ionic dependence of Ca2+ channel modulation by syntaxin 1A.
Alteration of the kinetic properties of voltage-gated Ca(2+) channels, Ca(v)1.2 (Lc-type), Ca(v)2.2 (N type), and Ca(v)2.3 (R type), by syntaxin 1A (Syn1A) and synaptotagmin could modulate exocytosis. We tested how switching divalent charge carriers from Ca(2+) to Sr(2+) and Ba(2+) affected Syn1A and synaptotagmin modulation of Ca(2+)-channel activation. Syn1A accelerated Ca(v)1.2 activation if Ca(2+) was the charge carrier; and by substituting for Ba(2+), Syn1A slowed Ca(v)1.2 activation. Syn1A also significantly accelerated Ca(v)2.3 activation in Ca(2+) and marginally in Ba(2+). Synaptotagmin, on the other hand, increased the rate of activation of Ca(v)2.3 and Ca(v)2.2 in all permeating ions tested. The Syn1A-channel interaction, unlike the synaptotagmin-channel interaction, proved significantly more sensitive to the type of permeating ion. It is well established that exocytosis is affected by switching the charge carriers. Based on the present results, we suggest that the channel-Syn1A interaction could respond to the conformational changes induced within the channel during membrane depolarization and divalent ion binding. These changes could partially account for the charge specificity of synaptic transmission as well as for the fast signaling between the Ca(2+) source and the fusion apparatus of channel-associated-vesicles (CAV). Furthermore, propagation of conformational changes induced by the divalent ions appear to affect the concerted interaction of the channel with the fusion/docking machinery upstream to free Ca(2+) buildup and/or binding to a cytosolic Ca(2+) sensor. These results raise the intriguing possibility that the channel is the Ca(2+) sensor in the process of fast neurotransmitter release.
Wiser
Ofer
O
Department of Biological Chemistry Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Cohen
Roy
R
Atlas
Daphne
D
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism / Q000494:pharmacology*; D001464:Barium / Q000378:metabolism / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D015220:Calcium Channels / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D002135:Calcium-Binding Proteins; D002413:Cations, Divalent / Q000378:metabolism / Q000494:pharmacology*; D004553:Electric Conductivity; D005071:Evoked Potentials / Q000187:drug effects; D015640:Ion Channel Gating / Q000187:drug effects*; D008562:Membrane Glycoproteins / Q000378:metabolism / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000378:metabolism / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D021122:Protein Subunits; D051381:Rats; D050857:Synaptotagmins; D050827:Syntaxin 1; D014982:Xenopus laevis
D000954:Antigens, Surface; D015220:Calcium Channels; D002135:Calcium-Binding Proteins; D002413:Cations, Divalent; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D021122:Protein Subunits; C494213:Stx1a protein, rat; D050827:Syntaxin 1; D050857:Synaptotagmins; D001464:Barium; D002118:Calcium